Viewing Study NCT00016432


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-02-22 @ 2:45 PM
Study NCT ID: NCT00016432
Status: COMPLETED
Last Update Posted: 2011-04-19
First Post: 2001-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Sponsor: NSABP Foundation Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage I breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View